Literature DB >> 3005173

Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies.

J A Montaraz, A J Winter, D M Hunter, B A Sowa, A M Wu, L G Adams.   

Abstract

Mice injected with either of two monoclonal antibodies specific for the O polysaccharide of Brucella abortus prior to challenge infection had viable counts in spleens and livers significantly below those in control groups 1 and 4 weeks later. Two monoclonal antibodies specific for the porin of B. abortus failed to confer protection.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3005173      PMCID： PMC260994          DOI： 10.1128/iai.51.3.961-963.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum.

Authors:  P Pardon
Journal:  Ann Immunol (Paris)       Date:  1977 Nov-Dec

2.  In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection.

Authors:  H Pavlov; M Hogarth; I F McKenzie; C Cheers
Journal:  Cell Immunol       Date:  1982-07-15       Impact factor: 4.868

3.  Brucella antigen preparations for in vitro lymphocyte immunostimulation assays in bovine brucellosis.

Authors:  J M Kaneene; R K Anderson; D W Johnson; C C Muscoplat
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  Evaluation of the enzyme-linked immunosorbent assay for detecting Brucella abortus antibodies.

Authors:  J W Byrd; F C Heck; R J Hidalgo
Journal:  Am J Vet Res       Date:  1979-06       Impact factor: 1.156

5.  Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein.

Authors:  E J Hansen; S M Robertson; P A Gulig; C F Frisch; E J Haanes
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

6.  Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.

Authors:  S Bascoul; A Cannat; M F Huguet; A Serre
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

7.  Outer membrane proteins of Brucella abortus: isolation and characterization.

Authors:  D R Verstreate; M T Creasy; N T Caveney; C L Baldwin; M W Blab; A J Winter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Haemolysis in gel test for detecting bovine antibodies to Brucella abortus lipopolysaccharide.

Authors:  K H Nielsen; B Rosenbaum; J M Stiller
Journal:  Res Vet Sci       Date:  1983-01       Impact factor: 2.534

9.  Immune serum-mediated effects on brucellosis evolution in mice.

Authors:  M Plommet; A M Plommet
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307
View more
  48 in total

1.  Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

Authors:  L E Lindler; T L Hadfield; B D Tall; N J Snellings; F A Rubin; L L Van De Verg; D Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum.

Authors:  L N Araya; A J Winter
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

Authors:  Neeta Jain-Gupta; Araceli Contreras-Rodriguez; Ramesh Vemulapalli; Sharon G Witonsky; Stephen M Boyle; Nammalwar Sriranganathan
Journal:  FEMS Immunol Med Microbiol       Date:  2012-12

5.  Immunological response to the Brucella abortus GroEL homolog.

Authors:  J Lin; L G Adams; T A Ficht
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.

Authors:  H S Warren; M L Glennon; N Wainwright; S F Amato; K M Black; S J Kirsch; G R Riveau; R I Whyte; W M Zapol; T J Novitsky
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice.

Authors:  A G Doyle; W J Halliday; C J Barnett; T L Dunn; D A Hume
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  R A Bowden; A Cloeckaert; M S Zygmunt; S Bernard; G Dubray
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.